Fintel reports that on April 21, 2025, B of A Securities upgraded their outlook for United Therapeutics (NasdaqGS:UTHR) from ...

United Therapeutics will host a public webcast Wednesday ... technologies that expand the availability of transplantable organs. You can learn more about what it means to be a PBC here ...

United Therapeutics Corporation ... which are development-stage organ products. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable ...

Key Takeaways A new trial will beging testing pig livers to support people with sudden liver failureThe pig liver won't be ...

For the first time since 2016, I enjoyed time with friends and family without planning around dialysis treatments,” the patient said in a statement.

PANJWANI: I’m Haya Panjwani. On this episode of The Story Behind the AP Story, we hear from Lauren Neergaard and Shelby Lum, ...

The study is part of a larger push to see if organs from gene-edited pigs can be used to help people. Other trials are testing pig kidneys from both eGenesis and United Therapeutics in ...

Regulus Therapeutics Inc.’s RGLS share price has surged by 5.41%, which has investors questioning if this is right time to sell.